Calithera Biosciences, Inc. · OTC:CALA

Calithera Biosciences — Technical Presentation (December 2014)

13 slides from Calithera Biosciences's technical presentation, December 2014

  1. Slide 1: Biomarkers of Response to the Glutaminase Inhibitor CB-839 in Multiple Myeloma Cells

    Biomarkers of Response to the Glutaminase Inhibitor CB-839 in Multiple Myeloma Cells Andrew MacKinnon, Mark Bennett, Mirna Rodriguez, and Francesco Parlati Calithera Biosciences, South San Francisco, CA Abstract #3429 2014 American Society of Hematology Annual Meeting -- December 6-9, 2014 -- San Fr

  2. Slide 2: Abstract #3429: Biomarkers of Response to CB-839

    Abstract #3429: MacKinnon et al. Biomarkers of Response to the Glutaminase Inhibitor CB-839 in Multiple Myeloma Cells American Society of Hematology Annual Meeting -- December 6-9, 2014 -- San Francisco, CA 2

  3. Slide 3: Abstract #3429: Biomarkers of Response to CB-839

    Abstract #3429: MacKinnon et al. Biomarkers of Response to the Glutaminase Inhibitor CB-839 in Multiple Myeloma Cells American Society of Hematology Annual Meeting -- December 6-9, 2014 -- San Francisco, CA 3

  4. Slide 4: Abstract #3429: Biomarkers of Response to CB-839

    Abstract #3429: MacKinnon et al. Biomarkers of Response to the Glutaminase Inhibitor CB-839 in Multiple Myeloma Cells American Society of Hematology Annual Meeting -- December 6-9, 2014 -- San Francisco, CA 4

  5. Slide 5: Abstract #3429: Biomarkers of Response to CB-839

    Abstract #3429: MacKinnon et al. Biomarkers of Response to the Glutaminase Inhibitor CB-839 in Multiple Myeloma Cells American Society of Hematology Annual Meeting -- December 6-9, 2014 -- San Francisco, CA 5

  6. Slide 6: Abstract #3429: Biomarkers of Response to CB-839

    Abstract #3429: MacKinnon et al. Biomarkers of Response to the Glutaminase Inhibitor CB-839 in Multiple Myeloma Cells American Society of Hematology Annual Meeting -- December 6-9, 2014 -- San Francisco, CA 6

  7. Slide 7: Abstract #3429: Biomarkers of Response to CB-839

    Abstract #3429: MacKinnon et al. Biomarkers of Response to the Glutaminase Inhibitor CB-839 in Multiple Myeloma Cells American Society of Hematology Annual Meeting -- December 6-9, 2014 -- San Francisco, CA 7

  8. Slide 8: Abstract #3429: Biomarkers of Response to CB-839

    Abstract #3429: MacKinnon et al. Biomarkers of Response to the Glutaminase Inhibitor CB-839 in Multiple Myeloma Cells American Society of Hematology Annual Meeting -- December 6-9, 2014 -- San Francisco, CA 8

  9. Slide 9: Abstract #3429: Biomarkers of Response to CB-839

    Abstract #3429: MacKinnon et al. Biomarkers of Response to the Glutaminase Inhibitor CB-839 in Multiple Myeloma Cells American Society of Hematology Annual Meeting -- December 6-9, 2014 -- San Francisco, CA 9

  10. Slide 10: Abstract #3429: Biomarkers of Response to CB-839

    Abstract #3429: MacKinnon et al. Biomarkers of Response to the Glutaminase Inhibitor CB-839 in Multiple Myeloma Cells American Society of Hematology Annual Meeting -- December 6-9, 2014 -- San Francisco, CA 10

  11. Slide 11: Abstract #3429: Biomarkers of Response to CB-839

    Abstract #3429: MacKinnon et al. Biomarkers of Response to the Glutaminase Inhibitor CB-839 in Multiple Myeloma Cells American Society of Hematology Annual Meeting -- December 6-9, 2014 -- San Francisco, CA 11

  12. Slide 12: Abstract #3429: Biomarkers of Response to CB-839

    Abstract #3429: MacKinnon et al. Biomarkers of Response to the Glutaminase Inhibitor CB-839 in Multiple Myeloma Cells American Society of Hematology Annual Meeting -- December 6-9, 2014 -- San Francisco, CA 12

  13. Slide 13: Abstract #3429: Biomarkers of Response to CB-839

    Abstract #3429: MacKinnon et al. Biomarkers of Response to the Glutaminase Inhibitor CB-839 in Multiple Myeloma Cells American Society of Hematology Annual Meeting -- December 6-9, 2014 -- San Francisco, CA 13

Calithera Biosciences — Technical Presentation (December 2014) on 6ix